Merck KgaaMKGAF
13F holders, Q2 2026 (June 30)3holders
0new positions
0sold out
$167.42avg. 13F price*
At the end of Q2 2026, 3 institutions reported holding Merck Kgaa (MKGAF) in their 13F filings, unchanged from Q1 2026. 0 opened new positions and 0 sold out. The largest holders were Generali Investments CEE, investicni spolecnost, a.s. ($1.0M), Reik & Co., LLC ($671K) and GAMMA Investing LLC ($6K).
- Company
- Merck Kgaa
- CUSIP
- D5357W103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 3 holders
| Generali Investments CEE, investicni spolecnost, a.s. | 0.05% | No change | 6,236 | $1.0M |
| Reik & Co., LLC | 0.17% | No change | 4,000 | $671K |
| GAMMA Investing LLC | 0.00% | No change | 34 | $6K |
"% of holder's portfolio" is MKGAF's weight in each manager's 13F, not the share of Merck Kgaa the manager owns.